loading
전일 마감가:
$7.84
열려 있는:
$7.8
하루 거래량:
262.71K
Relative Volume:
2.61
시가총액:
$221.56M
수익:
$21.25M
순이익/손실:
$-16.05M
주가수익비율:
-12.92
EPS:
-0.61
순현금흐름:
$-17.14M
1주 성능:
+0.25%
1개월 성능:
-9.63%
6개월 성능:
-4.95%
1년 성능:
+66.95%
1일 변동 폭
Value
$7.66
$8.21
1주일 범위
Value
$7.66
$9.00
52주 변동 폭
Value
$4.68
$9.92

Fennec Pharmaceuticals Inc Stock (FENC) Company Profile

Name
명칭
Fennec Pharmaceuticals Inc
Name
전화
(919) 636-4530
Name
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Name
직원
32
Name
트위터
@FennecPharma
Name
다음 수익 날짜
2025-03-10
Name
최신 SEC 제출 서류
Name
FENC's Discussions on Twitter

FENC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FENC
Fennec Pharmaceuticals Inc
7.88 267.76M 21.25M -16.05M -17.14M -0.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-11-22 업그레이드 Cantor Fitzgerald Neutral → Overweight
2022-09-07 개시 CapitalOne Overweight
2022-08-08 재개 Craig Hallum Buy
2020-06-05 개시 Cantor Fitzgerald Overweight
2018-10-11 개시 Goldman Buy

Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스

pulisher
05:17 AM

What analysts say about Fennec Pharmaceuticals Inc RV41 stockLarge Cap Stability Picks & Low Risk Investment Portfolio - earlytimes.in

05:17 AM
pulisher
Nov 22, 2025

(FRX) Strategic Investment Report (FRX:CA) - news.stocktradersdaily.com

Nov 22, 2025
pulisher
Nov 22, 2025

Fennec Pharmaceuticals Completes Full Debt Redemption, Strengthening Financial Position - MSN

Nov 22, 2025
pulisher
Nov 21, 2025

Is Fennec Pharmaceuticals Inc. (RV41) stock attractive post correctionTrade Volume Report & Consistent Profit Focused Trading Strategies - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Fennec Pharmaceuticals Inc. (RV41) stock performs in volatility spikesWatch List & Daily Entry Point Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Fennec Pharmaceuticals Inc. stock benefit from commodity pricesJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Fennec Pharmaceuticals Inc. (RV41) stock trades pre earningsJuly 2025 Action & AI Enhanced Trading Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

What dividend safety score for Fennec Pharmaceuticals Inc. stockJuly 2025 Fed Impact & High Yield Stock Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Southpoint Capital Advisors LP sells Fennec Pharmaceuticals shares By Investing.com - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 20, 2025

Southpoint Capital Advisors LP sells Fennec Pharmaceuticals shares - Investing.com India

Nov 20, 2025
pulisher
Nov 20, 2025

Fennec Pharmaceuticals Closes $5M Private Offering in Canada - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

How analysts revise price targets for Fennec Pharmaceuticals Inc. (RV41) stock2025 Top Gainers & Daily Profit Maximizing Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can Fennec Pharmaceuticals Inc. (RV41) stock withstand sector downturnsRisk Management & Weekly Chart Analysis and Guides - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Fennec Pharmaceuticals Inc. (RV41) stock is favored by hedge fundsPortfolio Risk Report & Real-Time Market Trend Scan - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Stocks in play: Fennec Pharmaceuticals Inc. - The Globe and Mail

Nov 19, 2025
pulisher
Nov 19, 2025

Can Fennec Pharmaceuticals Inc. stock maintain growth trajectoryJuly 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Fennec Pharmaceuticals repays all outstanding convertible notes By Investing.com - Investing.com Nigeria

Nov 19, 2025
pulisher
Nov 19, 2025

Will Fennec Pharmaceuticals Inc. (RV41) stock benefit from Fed rate cutsJuly 2025 Action & Smart Allocation Stock Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Fennec Pharmaceuticals stock rises after repaying all debt By Investing.com - Investing.com Canada

Nov 19, 2025
pulisher
Nov 19, 2025

Fennec Pharmaceuticals stock rises after repaying all debt - Investing.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Fennec Pharmaceuticals Inc. stock withstand economic slowdownAnalyst Upgrade & Scalable Portfolio Growth Methods - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Fennec Pharmaceuticals repays all outstanding convertible notes - Investing.com

Nov 19, 2025
pulisher
Nov 19, 2025

Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption - The Manila Times

Nov 19, 2025
pulisher
Nov 19, 2025

Fennec Pharmaceuticals Brief: Announcing Completion Of Full Debt Redemption - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

Can momentum traders help lift Fennec Pharmaceuticals Inc.Weekly Trade Recap & Scalable Portfolio Growth Methods - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Fennec Pharmaceuticals Inc. (RV41) stock cheap vs fundamentals2025 Momentum Check & Real-Time Market Trend Scan - newser.com

Nov 19, 2025

Fennec Pharmaceuticals Inc (FENC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Fennec Pharmaceuticals Inc 주식 (FENC) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Southpoint Capital Advisors LP
10% Owner
Nov 14 '25
Sale
8.00
160,100
1,280,432
3,850,000
Southpoint Capital Advisors LP
10% Owner
Nov 17 '25
Sale
8.79
85,918
755,193
3,764,082
Raykov Rosty
Director
Nov 05 '25
Sale
8.10
10,000
81,000
82,318
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
자본화:     |  볼륨(24시간):